Under the agreement, Bionoetikos will distribute Eksigent's NanoLC-1D and NanoLC-2D proteomics systems in Taiwan, the Philippines, Vietnam, Malaysia, Singapore, Thailand, Laos, and Cambodia, Eksigent said.

 

Mark Daniels, managing director at Bionoetikos, said in a statement that "the need for advanced proteomics and other drug discovery technologies [in that region] will continue to grow."